CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 45 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,964,000 | +497.6% | 228,015 | -23.7% | 0.01% | +333.3% |
| Q1 2020 | $496,000 | -10.3% | 298,649 | +20.4% | 0.00% | 0.0% |
| Q4 2019 | $553,000 | +1.1% | 248,066 | -3.2% | 0.00% | +50.0% |
| Q3 2019 | $547,000 | -23.8% | 256,308 | -4.2% | 0.00% | -33.3% |
| Q2 2019 | $718,000 | -0.7% | 267,557 | +82.0% | 0.00% | 0.0% |
| Q1 2019 | $723,000 | – | 147,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |